Today PHENOLEXA’s partner NCU represents the project at the 17th World Congress on Public Health in Rome
2 May 2023
“A world in turmoil: opportunities to focus on public health” – that is the motto of the 17th World Congress on Public Health that took place from the 2nd to 6th of May 2023 in Rome, Italy.
The congress is organised by the World Federation of Public Health Associations (WFPHA) in association with the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI) and the Association of Schools of Public Health in the European Region (ASPHER). Over 3.000 public health professionals and researchers, policymakers, and students convened to the event. The PHENOLEXA project is represented by our partner NCU.
Explained in brief, the congress stands for the global health community working on a concept promoting health equity & build sustainable future.
This year’s World Congress on Public Health draws attention to many critical problems of our time. The COVID-19 pandemic has changed our planet and our lives forever, exacerbating existing inequalities and warning us of the dangers of unsustainable production methods. Also, the many conflicts and wars around the world e.g. Ukraine-war and Afghanistan-war, have shown us how destabilised the world can be and how fragile some peace is. Because the consequences are received by all. Furthermore, our failure to mitigate the effects of climate change, environmental disasters are increasing in frequency and impact. That entails many problems for the health and living conditions of the people.
That’s why now more than ever, these crises are an opportunity to advocate for and build better social protection systems that promote health for all, prepare for the challenges of future pandemics and global crises. At the congress, there was an exchange on innovative solutions to achieve this as quickly and effectively as possible and to shape a sustainable future for public health in all sectors.
One of our partners also had the opportunity to attend the congress. The Nicolaus Copernicus University (NCU) from Poland, whose role in PHENOLEXA is the in vitro studies of anti-cancer and cardio wound healing activities of bioactives, had the opportunity to present a poster on “Clinical safety of natural compounds, an evidence-based approach”.
